|
C16ORF13 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.41439999999682E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.434500E-04 |
| Normal-vs-Stage2 |
1.590490E-02 |
| Normal-vs-Stage3 |
1.299570E-03 |
| Normal-vs-Stage4 |
3.564600E-04 |
| Stage1-vs-Stage2 |
5.356400E-01 |
| Stage1-vs-Stage3 |
6.067200E-01 |
| Stage1-vs-Stage4 |
1.422610E-01 |
| Stage2-vs-Stage3 |
7.530000E-01 |
| Stage2-vs-Stage4 |
6.671400E-01 |
| Stage3-vs-Stage4 |
3.573200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.0199000000003E-05 |
| Normal-vs-AfricanAmerican |
2.885800E-02 |
| Normal-vs-Asian |
2.871700E-02 |
| Caucasian-vs-AfricanAmerican |
7.461400E-01 |
| Caucasian-vs-Asian |
9.794200E-01 |
| AfricanAmerican-vs-Asian |
7.884000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.039430E-04 |
| Normal-vs-Female |
1.982720E-04 |
| Male-vs-Female |
3.731200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.284600E-03 |
| Normal-vs-Age(41-60Yrs) |
1.222090E-04 |
| Normal-vs-Age(61-80Yrs) |
2.818000E-03 |
| Normal-vs-Age(81-100Yrs) |
4.594000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.416600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.438400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.639200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.367000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.839400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.121400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.276000E-01 |
| Classical-VS-Follicular |
1.185360E-01 |
| Classical-VS-Other |
1.545590E-01 |
| Classical-VS-Normal |
3.197300E-04 |
| Tall-VS-Follicular |
1.131170E-01 |
| Tall-VS-Other |
1.306610E-01 |
| Tall-VS-Normal |
1.350400E-01 |
| Follicular-VS-Other |
5.949600E-01 |
| Follicular-VS-Normal |
2.156500E-04 |
| Other-VS-Normal |
7.472100E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.03779999999876E-05 |
| Normal-vs-N1 |
3.602000E-04 |
| N0-vs-N1 |
2.102000E-01 |
|
|
